Andrew S. Tasker

2.8k total citations
45 papers, 1.4k citations indexed

About

Andrew S. Tasker is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Andrew S. Tasker has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Organic Chemistry and 8 papers in Physiology. Recurrent topics in Andrew S. Tasker's work include Nitric Oxide and Endothelin Effects (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Synthesis and biological activity (5 papers). Andrew S. Tasker is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Synthesis and biological activity (5 papers). Andrew S. Tasker collaborates with scholars based in United States, United Kingdom and Canada. Andrew S. Tasker's co-authors include Ryan P. Wurz, Terry J. Opgenorth, William J. Chiou, Thomas W von Geldern, Bryan K. Sorensen, Martin Winn, Douglas B. Dixon, Robert W. Steel, Victor J. Cee and Seng-Lai Tan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Andrew S. Tasker

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew S. Tasker United States 20 681 482 230 185 132 45 1.4k
Tomohiro Kawamoto Japan 24 1.1k 1.6× 473 1.0× 301 1.3× 138 0.7× 243 1.8× 61 1.9k
Adam B. Keeton United States 25 1.1k 1.7× 451 0.9× 349 1.5× 83 0.4× 158 1.2× 84 1.8k
John H. Hutchinson United States 26 882 1.3× 654 1.4× 147 0.6× 275 1.5× 146 1.1× 90 1.9k
Benjamin Le Calvé Belgium 20 818 1.2× 345 0.7× 264 1.1× 223 1.2× 159 1.2× 31 1.6k
Laurie Churchill United States 13 686 1.0× 260 0.5× 263 1.1× 208 1.1× 156 1.2× 20 1.3k
Peppi Prasit United States 21 592 0.9× 242 0.5× 126 0.5× 234 1.3× 120 0.9× 44 1.2k
William Seibel United States 22 943 1.4× 438 0.9× 176 0.8× 68 0.4× 89 0.7× 66 1.6k
Heather N. Tinsley United States 18 775 1.1× 383 0.8× 168 0.7× 91 0.5× 95 0.7× 36 1.3k
Xiaoshan Min United States 22 1.3k 1.9× 206 0.4× 199 0.9× 252 1.4× 220 1.7× 34 2.0k
Steven Magnuson United States 18 952 1.4× 424 0.9× 249 1.1× 61 0.3× 182 1.4× 23 1.5k

Countries citing papers authored by Andrew S. Tasker

Since Specialization
Citations

This map shows the geographic impact of Andrew S. Tasker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Tasker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Tasker more than expected).

Fields of papers citing papers by Andrew S. Tasker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew S. Tasker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Tasker. The network helps show where Andrew S. Tasker may publish in the future.

Co-authorship network of co-authors of Andrew S. Tasker

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Tasker. A scholar is included among the top collaborators of Andrew S. Tasker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Tasker. Andrew S. Tasker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sickmier, E. Allen, et al.. (2016). The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance. PLoS ONE. 11(9). e0163366–e0163366. 55 indexed citations
2.
Cee, Victor J., Laurie P. Volak, Yuping Chen, et al.. (2015). Systematic Study of the Glutathione (GSH) Reactivity ofN-Arylacrylamides: 1. Effects of Aryl Substitution. Journal of Medicinal Chemistry. 58(23). 9171–9178. 110 indexed citations
3.
Wu, Bin, Huiling Wang, Victor J. Cee, et al.. (2015). Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(4). 775–780. 20 indexed citations
4.
Harrington, Paul E., Kaustav Biswas, David J. Malwitz, et al.. (2014). Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability. ACS Medicinal Chemistry Letters. 6(1). 68–72. 74 indexed citations
5.
Lanman, Brian A., Anthony B. Reed, Victor J. Cee, et al.. (2014). Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511. Bioorganic & Medicinal Chemistry Letters. 24(24). 5630–5634. 3 indexed citations
6.
Ou, Yi-Hung, Michael J. Torres, Rosalyn Ram, et al.. (2011). TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation. Molecular Cell. 41(4). 458–470. 174 indexed citations
7.
Reed, Anthony B., Brian A. Lanman, Susana Neira, et al.. (2011). Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups. Bioorganic & Medicinal Chemistry Letters. 22(4). 1779–1783. 5 indexed citations
8.
9.
Zeng, Qingping, Matthew P. Bourbeau, Holger Monenschein, et al.. (2010). 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20(5). 1652–1656. 15 indexed citations
10.
Caenepeel, Sean, Lisa Renshaw-Gegg, Tammy L. Bush, et al.. (2010). Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors. Journal of Experimental & Clinical Cancer Research. 29(1). 96–96. 15 indexed citations
11.
Wurz, Ryan P., Liping H. Pettus, Shimin Xu, et al.. (2009). Part 1: Structure–Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38α mitogen-activated protein kinase. Bioorganic & Medicinal Chemistry Letters. 19(16). 4724–4728. 17 indexed citations
12.
Kunz, Roxanne K., Dawei Zhang, Andrew S. Tasker, et al.. (2008). Discovery of amido-benzisoxazoles as potent c-Kit inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5115–5117. 10 indexed citations
13.
Kaufman, Stephen A., Charlie Starnes, Angela Coxon, et al.. (2006). AMG 706 induces the rapid destruction of tumor microvessels in nude mice. Cancer Research. 66. 892–892. 2 indexed citations
14.
Kim, Tae‐Seong, Christopher M. Tegley, Xianghong Wang, et al.. (2003). (4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 87–90. 6 indexed citations
15.
Boyd, Steven A., Robert A. Mantei, Andrew S. Tasker, et al.. (1999). Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity. Bioorganic & Medicinal Chemistry. 7(6). 991–1002. 10 indexed citations
16.
Winn, Martin, Thomas W von Geldern, Terry J. Opgenorth, et al.. (1996). 2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ETA Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722. Journal of Medicinal Chemistry. 39(5). 1039–1048. 98 indexed citations
17.
Chiou, William J., Kazumi Shiosaki, Andrew S. Tasker, & Jinshyun R. Wu‐Wong. (1994). Characterization of two endothelin converting enzymes and their preference for big endothelin-1 and -2 as substrates. Life Sciences. 54(21). 1613–1619. 5 indexed citations
18.
Steel, Robert W., et al.. (1994). A total synthesis of gelsemine: oxindole spiroannelation. Journal of the Chemical Society Chemical Communications. 765–765. 41 indexed citations
19.
Surber, Bruce W., Samuel Thomas, Andrew S. Tasker, et al.. (1994). [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors. European Journal of Pharmacology Molecular Pharmacology. 267(1). 49–54. 3 indexed citations
20.
Shiosaki, Kazumi, Andrew S. Tasker, Gerard M. Sullivan, et al.. (1993). Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung. Journal of Medicinal Chemistry. 36(4). 468–478. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohiro Kawamoto Breakdown of academic impact, for papers by Adam B. Keeton Breakdown of academic impact, for papers by John H. Hutchinson Breakdown of academic impact, for papers by Benjamin Le Calvé Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by Peppi Prasit Breakdown of academic impact, for papers by William Seibel Breakdown of academic impact, for papers by Heather N. Tinsley Breakdown of academic impact, for papers by Xiaoshan Min Breakdown of academic impact, for papers by Steven Magnuson
Rankless by CCL
2026